Stay updated on Tezepelumab in Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.

Latest updates to the Tezepelumab in Chronic Urticaria Clinical Trial page
- ChecktodayChange DetectedThe page revision has been updated from v3.6.5 to v3.6.6, indicating a minor platform update.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page shows a new revision number (v3.6.5) replacing the previous version, signaling a post-publication update to the study page.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page revision label was updated from v3.6.3 to v3.6.4, indicating a small system update. No study details, eligibility criteria, or results appear to be affected by this change.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page footer now shows a new Revision: v3.6.3 tag, replacing the previous v3.6.2, indicating an update to the study record.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a new page build. This likely reflects internal UI/backend updates but does not alter the study details presented.SummaryDifference0.0%

- Check78 days agoChange DetectedRecruitment status now indicates enrollment is closed; new guidance and navigation sections were added, and the Intervention/Treatment header was reformatted with a new page revision marker (v3.6.0).SummaryDifference0.2%

Stay in the know with updates to Tezepelumab in Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tezepelumab in Chronic Urticaria Clinical Trial page.